Online citations, reference lists, and bibliographies.
← Back to Search

Biodegradable Polymers For The Controlled Release Of Ocular Drugs

A. Merkli, C. Tabatabay, R. Gurny, J. Heller
Published 1998 · Materials Science

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1016/0378-5173(87)90050-0
A γ-scintigraphic evaluation of microparticulate ophthalmic delivery systems: liposomes and nanoparticles
P. Fitzgerald (1987)
10.1016/0378-5173(85)90005-5
Systemic absorption of ocular pilocarpine is modified by polymer matrices
A. Urtti (1985)
10.1007/BF00701077
Structure-property relationships in the case of the degradation of massive poly(α-hydroxy acids) in aqueous media
S. Li (1990)
10.1016/0378-5173(89)90334-7
Distribution of poly-hexyl-2-cyano-[3-14C]acrylate nanoparticles in healthy and chronically inflamed rabbit eyes
R. Diepold (1989)
10.1089/JOP.1992.8.191
Reduction of cardiovascular side effects associated with ocular administration of metipranolol by inclusion in polymeric nanocapsules.
C. Losa (1992)
10.1016/0168-3659(95)00074-I
Controlled intraocular delivery of ganciclovir with use of biodegradable scleral implant in rabbits
N. Kunou (1995)
10.1016/0378-5173(90)90248-3
Antiglaucomatous activity of betaxolol chlorhydrate sorbed onto different isobutylcyanoacrylate nanoparticle preparations
L. Marchal-Heussler (1990)
10.1002/JPS.2600690725
Immobilization of proteins in microspheres of biodegradable polyacryldextran.
P. Edman (1980)
10.1007/BF00752233
Biodegradation of surgical polymers
D. Williams (1982)
10.1163/156856293X00168
Synthesis and characterization of a new biodegradable semi-solid poly(ortho ester) for drug delivery systems.
A. Merkli (1993)
10.1016/0168-3659(94)00117-D
The use of acidic and basic excipients in the release of 5-fluorouracil and mitomycin C from a semi-solid bioerodible poly(ortho ester)
A. Merkli (1995)
10.1021/MA00170A001
Synthesis of polyanhydrides: melt-polycondensation, dehydrochlorination, and dehydrative coupling
K. Leong (1987)
10.1002/JPS.2600800712
Timolol release from matrices of monoesters of poly(vinyl methyl ether-maleic anhydride): effects of polymer molecular weight and a basic additive.
U. Finne (1991)
10.1001/ARCHOPHT.1992.01080140111037
Intravitreal sustained-release ganciclovir.
T. J. Smith (1992)
10.1016/0142-9612(91)90037-B
Physico-mechanical properties of degradable polymers used in medical applications: a comparative study.
I. Engelberg (1991)
10.1097/00000658-196010000-00009
Nonsuture closure of arterial incisions using a rapidly-polymerizing adhesive.
H. Nathan (1960)
10.1016/0378-5173(92)90376-D
Mechanisms of timolol release from monoisopropyl PVM-MA matrices with and without a basic salt
U. Finne (1992)
Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy.
T. Moritera (1992)
10.1111/j.2042-7158.1979.tb13510.x
Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties
P. Couvreur (1979)
10.1016/0378-5173(90)90004-N
Modification of ocular and systemic absorption of timolol from ocular inserts by a buffering agent and a vasoconstrictor
U. Finne (1990)
The use of bioerodible polymers and 5-fluorouracil in glaucoma filtration surgery.
D. Lee (1988)
10.1016/0168-3659(94)90126-0
Semi-solid hydrophobic bioerodible poly(ortho ester) for potential application in glaucoma filtering surgery
A. Merkli (1994)
10.1016/0142-9612(90)90003-9
Controlled drug release from bioerodible hydrophobic ointments.
J. Heller (1990)
Injectable microspheres with controlled drug release for glaucoma filtering surgery.
H. Kimura (1992)
10.2307/1965589
Long-acting contraceptive delivery systems.
G. Zatuchni (1985)
Glaucoma filtration surgery in nonhuman primates using taxol and etoposide in polyanhydride carriers.
H. Jampel (1993)
10.1016/S0161-6420(87)33251-8
Glaucoma filtration surgery in rabbits using bioerodible polymers and 5-fluorouracil.
D. Lee (1987)
10.1016/0168-3659(86)90001-5
Polymers for biodegradable medical devices. 1. The potential of polyesters as controlled macromolecular release systems
S. G. Holland (1986)
10.3109/02652048809056475
Possibilities of using nanoparticles as carriers for drugs and vaccines.
J. Kreuter (1988)
10.1001/ARCHOPHT.1992.01080140044023
Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis. Use of an intravitreal device.
G. Sanborn (1992)
10.1016/0142-9612(80)90060-5
Controlled release of biologically active compounds from bioerodible polymers.
J. Heller (1980)
10.1016/0142-9612(84)90002-4
Degradation of poly (isobutyl cyanoacrylate) nanoparticles.
V. Lenaerts (1984)
10.1016/S0140-6736(74)92473-8
Letter: Rooming-in.
B. Cox (1974)
10.1001/ARCHOPHT.1994.01090240037023
Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.
D. Martín (1994)
[Nanocapsules of beta-blocking agents: a new drug carrier in ophthalmology. Application to medical treatment of glaucoma in rabbits].
L. Marchal-Heussler (1991)
10.1089/JOP.1994.10.29
Microparticulates for ophthalmic drug delivery.
A. Joshi (1994)
10.1002/JBM.820190806
Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics.
K. Leong (1985)
10.1016/0168-3659(85)90055-0
Controlled release of macromolecules: Biological studies☆
R. Langer (1985)
Current uses of collagen shields.
R. Keates (1990)
10.1111/j.2042-7158.1991.tb03534.x
Improvement of Ocular Penetration of Amikacin Sulphate by Association to Poly(butylcyanoacrylate) Nanoparticles
C. Losa (1991)
10.1016/0168-3659(90)90070-A
Controlled release of 5-fluorouracil from linear poly(ortho esters)
Y. Maa (1990)
10.1002/APP.1979.070230212
Biodegradable polymers: Chymotrypsin degradation of a low molecular weight poly(ester‐urea) containing phenylalanine
S. Huang (1979)
10.1002/JBM.820200106
Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity.
K. Leong (1986)
Microspheres of biodegradable polymers as a drug-delivery system in the vitreous.
T. Moritera (1991)
10.1007/BFB0027551
Poly(Ortho Esters)
J. Heller (1993)
10.1016/0142-9612(83)90025-X
Controlled release of water-soluble macromolecules from bioerodible hydrogels.
J. Heller (1983)
10.1016/S0161-6420(91)32265-6
Use of bioerodible polymers impregnated with mitomycin in glaucoma filtration surgery in rabbits.
J. Charles (1991)
10.1016/0378-5173(85)90199-1
Pilocarpine release from matrices of alkyl half-esters of poly(vinyl methyl ether/maleic anhydride)
A. Urtti (1985)
10.1016/S0002-9394(14)72443-2
Primate trabeculectomies with 5-fluorouracil collagen implants.
B. Hasty (1990)
10.1016/0378-5173(85)90007-9
Ocular disposition of poly-hexyl-2-cyano[3-14C]acrylate nanoparticles in the albino rabbit
R. Wood (1985)
10.1001/ARCHOPHT.1994.01090220130035
Scleral plug of biodegradable polymers for controlled drug release in the vitreous.
M. Hashizoe (1994)
10.1016/0168-3659(87)90078-2
Use of poly(ortho esters) for the controlled release of 5-fluorouracyl and a LHRH analogue☆
J. Heller (1987)
10.1016/S0161-6420(91)32227-9
Device drug delivery to the eye. Collagen shields, iontophoresis, and pumps.
M. L. Friedberg (1991)
10.1002/APP.1978.070220720
Controlled drug release by polymer dissolution. I. Partial esters of maleic anhydride copolymers—properties and theory
J. Heller (1978)
10.1016/0142-9612(81)90060-0
Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (epsilon-caprolactone), and their copolymers in vivo.
C. Pitt (1981)
10.1002/JBM.820110208
Immobilization of enzymes on slowly soluble carriers.
V. Torchilin (1977)
10.1016/S0140-6736(75)91481-6
SOLUBLE OPHTHALMIC DRUG INSERTS
Y. Maichuk (1975)
10.1201/9780429284755
Biopharmaceutics of Ocular Drug Delivery
P. Edman (1992)
10.1016/0039-6257(84)90168-1
Ophthalmic drug delivery systems
J. Shell (1984)
10.1016/0168-3659(91)90058-L
Polyalkylcyanoacrylate nanoparticles as drug carrier: present state and perspectives
P. Couvreur (1991)
10.1016/0378-5173(91)90256-N
Sodium acetate improves the ocular/systemic absorption ratio of timolol applied ocularly in monoisopropyl PVM-MA matrices
U. Finne (1991)
10.1002/APP.1966.070100208
Synthesis and degradation of poly (alkyl α-cyanoacrylates)
F. Leonard (1966)
10.1080/07366578308079439
Chemical and Physical Structure of Polymers as Carriers for Controlled Release of Bioactive Agents: A Review
R. Langer (1983)
10.1002/JBM.820100204
Cellular enzyme activity at the polymer-tissue interface: a review.
T. N. Salthouse (1976)
10.1002/JPS.2600620712
Lacrimal and instilled fluid dynamics in rabbit eyes.
S. Chrai (1973)
10.1002/APP.1979.070240710
Synthesis of copolyamide–esters and some aspects involved in their hydrolysis by lipase
Y. Tokiwa (1979)
10.1016/b978-0-12-074450-3.x5001-3
Controlled release of bioactive materials.
R. Baker (1980)
10.1016/0020-711x(92)90058-9
Biodegradable polymers as drug delivery systems
M. Chasin (1990)
10.1016/0168-3659(89)90062-X
Drug release from monoisopropyl ester of poly(vinyl methyl ether-maleic anhydride) can be modified by basic salts in the polymer matrix
U. Finne (1989)
10.1016/0378-5173(92)90159-Y
Pharmacokinetic simulation reveals in vivo deviations from in vitro release of timolol from polymer matrices
U. Finne (1992)
10.1001/ARCHOPHT.1990.01070050128046
Glaucoma filtration surgery in monkeys using 5-fluorouridine in polyanhydride disks.
H. Jampel (1990)
10.3109/02652048609031575
Ocular drug delivery of progesterone using nanoparticles.
V. Li (1986)
10.1007/978-1-4613-1809-5
Polymers in Medicine II
E. Chiellini (1987)
10.1016/0378-5173(86)90053-0
Enhancement of the myotic response of rabbits with pilocarpine-loaded polybutylcyanoacrylate nanoparticles
T. Harmia (1986)
10.1016/1010-6030(88)80058-3
Development in Polymer Degradation — 7 : edited by N. Grassie; published by Elsevier Applied Science, London, 1987; 276 pp.; price £40.00
A. Chirinos-Padron (1988)
A new vitreal drug delivery system using an implantable biodegradable polymeric device.
H. Kimura (1994)
10.1021/JA01942A009
THE ANHYDRIDES OF ISOPHTHALIC AND TEREPHTHALIC ACIDS.
J. E. Bucher (1909)



This paper is referenced by
Sterol-based Organogel Drug Delivery Systems
Oliver Chung (2013)
ESTUDO DE PRÉ-FORMULAÇÃO DE NANOPARTÍCULAS POLIMÉRICAS PARA VEICULAÇÃO DA L-ASPARAGINASE
Camila de Oliveira Melo (2016)
10.1016/B978-0-323-39396-6.00005-1
Types of Biodegradable Polymers
Syed Ali Ashter (2016)
10.1002/jbm.a.34542
Subcutaneous tissue response to titanium, poly(ε-caprolactone), and carbonate-substituted hydroxyapatite-coated poly(ε-caprolactone) plates: a rabbit study.
N. Chanchareonsook (2013)
A Biodegradable Microparticle Vaccine Platform using Femtomole Peptide Antigen Doses to Elicit T-cell Immunity against Chlamydia abortus
E. Chowdhury (2016)
Preliminary study on the preparation of poly(D,L-lactide/propylene glycol) triblock and cross- linked copolymers
A. Zainuddin (2015)
10.1590/S1516-14392008000200016
Development and characterization of an intraocular biodegradable polymer system containing cyclosporine-A for the treatment of posterior uveitis
J. B. Saliba (2008)
Synthesis of Amphiphilic Block Copolymers for Use in Biomedical Applications
A. Carmichael-Baranauskas (2010)
10.1016/J.ADDR.2005.09.007
Ocular delivery using poly(ortho esters).
J. Heller (2005)
10.1016/j.ejmech.2010.05.037
Synthesis and characterization of polyester conjugates of ciprofloxacin.
M. Sobczak (2010)
10.3390/molecules15020842
Seeking Polymeric Prodrugs of Norfloxacin. Part 2. Synthesis and Structural Analysis of Polyurethane Conjugates
M. Sobczak (2010)
10.1023/A:1007517912927
Permeability and Diffusion in Vitreous Humor: Implications for Drug Delivery
Jing Xu (2004)
10.1533/9781845695033.5.357
Drug release from bioresorbable materials
D. Jones (2008)
10.1016/j.jconrel.2013.12.020
Solvent induced phase inversion-based in situ forming controlled release drug delivery implants.
R. Thakur (2014)
10.1002/POLA.28261
Preparation and functionalization of linear and reductively degradable highly branched cyanoacrylate-based polymers
Houliang Tang (2016)
10.13005/BBRA
Biodegradable Polycaprolactone Nanoparticles Based Drug Delivery Systems: A Short Review
R. Ramanujam (2018)
PROCESS FOR FORMATION OF CATIONIC POLY (LACTIC-CO-GLYCOLIC ACID) NANOPARTICLES USING STATIC MIXERS
Yamuna Reddy Charabudla (2008)
10.1016/B978-2-294-71107-7.50055-X
Chapitre 54 – Thérapeutiques oculaires ciblées
Francine Béhar-Cohen (2010)
10.1002/jbm.b.33077
Segmental mandibular bone reconstruction with a carbonate-substituted hydroxyapatite-coated modular endoprosthetic poly(ɛ-caprolactone) scaffold in Macaca fascicularis.
N. Chanchareonsook (2014)
10.1016/J.PROGPOLYMSCI.2010.04.002
The return of a forgotten polymer : Polycaprolactone in the 21st century
M. Woodruff (2009)
Crosslinked poly(ester anhydrides) for controlled drug delivery
R. Hakala (2013)
10.3109/10717544.2013.801052
Efficacy of methotrexate-loaded poly(ε-caprolactone) implants in Ehrlich solid tumor-bearing mice
Adriana De Fátima Pereira (2013)
10.1039/C4TB00548A
Drug-releasing implants: current progress, challenges and perspectives.
A. Santos (2014)
Drug Eluting Therapeutic Contact Lens
Hitesh Gohel ()
10.4236/JBNB.2012.32027
Synthesis and Characterization of Poly(D,L-Lactide-co-Glycolide) Copolymer
Cynthia D’Avila Carvalho Erbetta (2012)
10.1016/S0142-9612(03)00161-3
Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility.
E. Fournier (2003)
10.1208/s12249-009-9280-8
Stability Studies of Microparticulate System with Piroxicam as Model Drug
S. Puthli (2009)
10.1016/J.SUPFLU.2010.02.001
Development of therapeutic contact lenses using a supercritical solvent impregnation method
V. Costa (2010)
10.1016/J.JDDST.2017.11.012
Tacrolimus delivered from polymeric implants suppressed inflammation and angiogenesis in vivo without inducing nephrotoxicity, hepatotoxicity, and myelosuppression.
L. Oliveira (2018)
[Biodegradable systems containing prednisolone acetate for orbital administration].
R. M. D. Byrro (2009)
10.1016/S0169-409X(01)00220-4
Therapeutic applications of viscous and injectable poly(ortho esters).
S. Einmahl (2001)
10.1016/j.ejmech.2011.01.006
Use of aliphatic poly(amide urethane)s for the controlled release of 5-fluorouracil.
M. Sobczak (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar